• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Strength in Alexion Pharmaceuticals May Be Temporary

Be cautious about ALXN in the short-run.
By BRUCE KAMICH
Jul 27, 2020 | 03:25 PM EDT
Stocks quotes in this article: ALXN

Alexion Pharmaceuticals (ALXN) is up sharply Monday but this strength only looks temporary. Let's check out the charts and indicators. 

In the updated daily bar chart of ALXN, below, we can see that the shares briefly broke below the rising 200-day moving average line. Trading volume does not look like it expanded much on the break of the moving average line so it must not be of concern to the holders of ALXN.

The 50-day moving average line looks like it is rolling over and the On-Balance-Volume (OBV) line has rolled over so far this month. A declining OBV line means that sellers of a stock have become more aggressive.

The trend-following Moving Average Convergence Divergence (MACD) oscillator has moved below the zero line for an outright sell signal. 

 
In the weekly bar chart of ALXN, below, we see a mixed picture. Prices are testing the rising 40-week moving average line.
 
The OBV line has been weak since May and the MACD oscillator has been narrowing toward a possible bearish crossover. 
 
 
In this daily Point and Figure chart of ALXN, below, we can see a possible downside price target in the $95 area. 
 
 
 
Bottom-line strategy: While some state-of-the-art companies near Boston can turn on a dime I would be cautious about ALXN in the short-run.
 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Biotechnology | Pharmaceuticals

More from Stocks

Roku Has Corrected and Looks Ready for New Strength

Bruce Kamich
Apr 21, 2021 11:44 AM EDT

We have a strategy for aggressive traders.

Will a Bounce in the Broken Be Used as an Escape Hatch?

James "Rev Shark" DePorre
Apr 21, 2021 11:09 AM EDT

What will really make a difference is if the strength holds, and there is a strong close.

How Do You Play the Netflix Dip? Buy Disney

Stephen Guilfoyle
Apr 21, 2021 11:00 AM EDT

Here's my trading strategy.

Index Chart Trends See a Shift

Guy Ortmann
Apr 21, 2021 10:31 AM EDT

The 'wall of worry' is in need of repair.

DocuSign's Charts Have Strengthened

Bruce Kamich
Apr 21, 2021 10:10 AM EDT

Back to the Drawing Board

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:17 PM EDT REAL MONEY

    Wednesday on Real Money Pro

    Get-rich quick schemes offer little more than pipe...
  • 11:09 AM EDT GARY BERMAN

    S&P Futures

    FIBOCALL: The S&P futures was off 1.5 %... ...
  • 07:47 AM EDT CHRIS VERSACE

    Positive News for a Cannabis Play

    Good news for this name in the Stocks Under $10 po...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login